THE INFLUENCE OF SUNLIGHT EXPOSURE ON SERUM VITAMIN D CONCENTRATION AND BONE TURNOVER; A CONTROLLED CLINICAL TRIAL


Apocynin, a Selective NADPH Oxidase (Nox2) Inhibitor, Ameliorates Behavioural and Learning Deficits in the Fragile X Syndrome Mouse Model

Background/Objectives: Fragile X Syndrome (FXS) is associated with intellectual disability, hyperactivity, social anxiety and signs of autism.Hyperactivation of NADPH oxidase has been previously described in Easy Chair the brain of the male Fmr1-KO mouse.This work aims to demonstrate the efficacy of Apocynin, a specific NADPH oxidase inhibitor, in

read more